Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Colorcon
Dow
McKesson
Johnson and Johnson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

MENRIUM 5-2 Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Menrium 5-2 patents expire, and what generic alternatives are available?

Menrium 5-2 is a drug marketed by Roche and is included in one NDA.

The generic ingredient in MENRIUM 5-2 is chlordiazepoxide; estrogens, esterified. There are nine drug master file entries for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.

Summary for MENRIUM 5-2
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:MENRIUM 5-2 at DailyMed
Drug patent expirations by year for MENRIUM 5-2

US Patents and Regulatory Information for MENRIUM 5-2

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche MENRIUM 5-2 chlordiazepoxide; estrogens, esterified TABLET;ORAL 014740-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Express Scripts
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.